Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457886 · ClinicalTrials.gov registry record
Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery
A clinical trial of Preterm Delivery, sponsored by Georgetown University.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT00457886 is a study of Preterm Delivery that has completed, run by Georgetown University. The registered enrollment target is 20 participants, below the 779-participant average among 3 other Preterm Delivery trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00457886, a study of Preterm Delivery, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure hormones in the blood known to affect the timing of delivery after a single injection of 17-P in order to help understand its mechanism of action in preventing preterm delivery.
Conditions Studied
Study Locations (1)
District of Columbia
- Georgetown University Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-07 |
| Est. Completion | 2007-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00457886
The ClinicalTrials.gov registry entry for NCT00457886 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 779-participant average among 3 other Preterm Delivery trials with a reported enrollment target (97% lower). The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preterm Delivery appearing as the primary indexed condition, and to 0 interventions.
NCT00457886 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00457886 about?
NCT00457886 is a clinical study titled "Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery". The purpose of this study is to measure hormones in the blood known to affect the timing of delivery after a single injection of 17-P in order to help understand its mechanism of action in preventing preterm delivery.
What is the current status of trial NCT00457886?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2005-07. Estimated completion is 2007-06.
What conditions does trial NCT00457886 study?
This clinical trial studies the following conditions: Preterm Delivery.
Who is sponsoring clinical trial NCT00457886?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00457886 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Delivery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
RECRUITING · Phase 3
-
A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome
COMPLETED · Phase 4
-
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.